School of Medicine
Showing 261-280 of 425 Results
-
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Minh Dai Nguyen
Postdoctoral Scholar, Gastroenterology
BioDr. Minh Nguyen joined the Prof. Jeffrey Glenn laboratory as a postdoctoral scholar in August 2022. In collaboration with Safaran ChEM-H Medicinal Chemistry Knowledge Center, his research objective is to harness the power of organic synthesis toward the development of novel antiviral therapies. Minh obtained his Ph.D. in Chemistry from the University of Pennsylvania under the direction of Prof. Amos B. Smith, III, where his doctoral work centered on the convergent total synthesis of two marine natural products nahuoic acids Cii and Dii.
-
Minh Nguyen
Ph.D. Student in Biomedical Informatics, admitted Autumn 2018
Ph.D. Minor, Management Science and EngineeringBio@DARE fellow (Diversifying Academia, Recruiting Excellence) https://vpge.stanford.edu/people/minh-nguyen
@Data Science Scholar
https://datascience.stanford.edu/people/minh-nguyen -
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders. -
Teresa Phuongtram Nguyen
Clinical Instructor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Teresa Nguyen is a Resident Physician in Anesthesiology at Stanford Medicine. She is passionate about medical innovation and is committed to advancing science education and mentorship. Her research is focused on the intersection of AI and medicine where she studies the applications of large language models in healthcare and subsequent impacts on society. She also mentors students in the Stanford Robotics Team and leads research initiatives for investigating AI-enabled robots' application for improved pediatric care and outcomes. She is the instructor for Chem 93: "Chemistry Unleashed: Exploring the Chemistry that Transforms Our World" at the Stanford Department of Chemistry and is a helicopter pilot.
Dr. Nguyen completed her Bachelor of Science degree in Chemistry at Stanford University, where she was awarded a U.S. Department of State Critical Language Scholarship in Arabic and the Bing Fellowship for her research in Chemistry. She then became a Scientific Researcher at Genentech, where she co-invented and patented a series of drugs for the potential treatment of chronic and neuropathic pain. She attended and received her MD from Stanford University School of Medicine, where she was a Medical Scholars Research Fellow under the mentorship of Professor Carolyn Bertozzi (Nobel laureate in Chemistry 2022). She has published across several medical subspecialties, including head and neck surgery, rhinology, urology, and orthopedic surgery.
Dr. Nguyen is deeply passionate about diversity, equity, and inclusion initiatives. She is the founder of the Lighthouse Initiative, a nonprofit organization whose mission is to provide resources and mentorship to first-generation, low-income, and minority individuals, with a 100% success rate in aiding college admissions for its members. She is also the co-founder of Hands-On Robotics, a nonprofit organization which supports robotics initiatives and education.
